View in EDS

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.

Saved in:
Bibliographic Details
Title: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.
Authors: Agarwal R; Division of Nephrology, Richard L. Roudebush VA Medical Center, Indianapolis.; Indiana University School of Medicine, Indianapolis., Green JB; Division of Endocrinology, Department of Medicine and Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC., Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Mann JFE; KfH (Kuratorium für Dialyse und Nierentransplantation) Kidney Center, Munich, Germany.; Department of Nephrology and Hypertension, Friedrich Alexander University, Erlangen, Germany., McGill JB; Division of Endocrinology, Metabolism and Lipid Research, Washington University in St. Louis, School of Medicine, St. Louis., Mottl AK; University of North Carolina (UNC) Kidney Center, UNC School of Medicine, Chapel Hill., Rosenstock J; Velocity Clinical Research at Medical City, Dallas., Rossing P; Steno Diabetes Center Copenhagen, Copenhagen.; Department of Clinical Medicine, University of Copenhagen, Copenhagen., Vaduganathan M; Division of Cardiovascular Medicine, Brigham and Women's Hospital-Harvard Medical School, Boston., Brinker M; Cardiology and Nephrology Clinical Development, Bayer, Wuppertal, Germany., Edfors R; Department of Clinical Sciences, Danderyd University Hospital, Division of Cardiovascular Medicine, Karolinska Institutet, Stockholm., Li N; Bayer Healthcare, Chaoyang District, Beijing., Scheerer MF; Global Medical Affairs and Pharmacovigilance, Bayer, Berlin., Scott C; Clinical Statistics and Analytics, Bayer, Whippany, NJ., Nangaku M; Division of Nephrology and Endocrinology, University of Tokyo Graduate School of Medicine, Tokyo.
Corporate Authors: CONFIDENCE Investigators
Source: The New England journal of medicine [N Engl J Med] 2025 Aug 07; Vol. 393 (6), pp. 533-543. Date of Electronic Publication: 2025 Jun 05.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40470996
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Agarwal+R%22">Agarwal R</searchLink>; Division of Nephrology, Richard L. Roudebush VA Medical Center, Indianapolis.; Indiana University School of Medicine, Indianapolis.<br /><searchLink fieldCode="AU" term="%22Green+JB%22">Green JB</searchLink>; Division of Endocrinology, Department of Medicine and Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC.<br /><searchLink fieldCode="AU" term="%22Heerspink+HJL%22">Heerspink HJL</searchLink>; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Mann+JFE%22">Mann JFE</searchLink>; KfH (Kuratorium für Dialyse und Nierentransplantation) Kidney Center, Munich, Germany.; Department of Nephrology and Hypertension, Friedrich Alexander University, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22McGill+JB%22">McGill JB</searchLink>; Division of Endocrinology, Metabolism and Lipid Research, Washington University in St. Louis, School of Medicine, St. Louis.<br /><searchLink fieldCode="AU" term="%22Mottl+AK%22">Mottl AK</searchLink>; University of North Carolina (UNC) Kidney Center, UNC School of Medicine, Chapel Hill.<br /><searchLink fieldCode="AU" term="%22Rosenstock+J%22">Rosenstock J</searchLink>; Velocity Clinical Research at Medical City, Dallas.<br /><searchLink fieldCode="AU" term="%22Rossing+P%22">Rossing P</searchLink>; Steno Diabetes Center Copenhagen, Copenhagen.; Department of Clinical Medicine, University of Copenhagen, Copenhagen.<br /><searchLink fieldCode="AU" term="%22Vaduganathan+M%22">Vaduganathan M</searchLink>; Division of Cardiovascular Medicine, Brigham and Women's Hospital-Harvard Medical School, Boston.<br /><searchLink fieldCode="AU" term="%22Brinker+M%22">Brinker M</searchLink>; Cardiology and Nephrology Clinical Development, Bayer, Wuppertal, Germany.<br /><searchLink fieldCode="AU" term="%22Edfors+R%22">Edfors R</searchLink>; Department of Clinical Sciences, Danderyd University Hospital, Division of Cardiovascular Medicine, Karolinska Institutet, Stockholm.<br /><searchLink fieldCode="AU" term="%22Li+N%22">Li N</searchLink>; Bayer Healthcare, Chaoyang District, Beijing.<br /><searchLink fieldCode="AU" term="%22Scheerer+MF%22">Scheerer MF</searchLink>; Global Medical Affairs and Pharmacovigilance, Bayer, Berlin.<br /><searchLink fieldCode="AU" term="%22Scott+C%22">Scott C</searchLink>; Clinical Statistics and Analytics, Bayer, Whippany, NJ.<br /><searchLink fieldCode="AU" term="%22Nangaku+M%22">Nangaku M</searchLink>; Division of Nephrology and Endocrinology, University of Tokyo Graduate School of Medicine, Tokyo.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22CONFIDENCE+Investigators%22">CONFIDENCE Investigators</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220255562%22">The New England journal of medicine</searchLink> [N Engl J Med] 2025 Aug 07; Vol. 393 (6), pp. 533-543. <i>Date of Electronic Publication: </i>2025 Jun 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Massachusetts+Medical+Society%22">Massachusetts Medical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0255562 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1533-4406 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200284793%22">00284793 </searchLink><i>NLM ISO Abbreviation: </i>N Engl J Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40470996
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1056/NEJMoa2410659
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 533
    Titles:
      – TitleFull: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Agarwal R
      – PersonEntity:
          Name:
            NameFull: Green JB
      – PersonEntity:
          Name:
            NameFull: Heerspink HJL
      – PersonEntity:
          Name:
            NameFull: Mann JFE
      – PersonEntity:
          Name:
            NameFull: McGill JB
      – PersonEntity:
          Name:
            NameFull: Mottl AK
      – PersonEntity:
          Name:
            NameFull: Rosenstock J
      – PersonEntity:
          Name:
            NameFull: Rossing P
      – PersonEntity:
          Name:
            NameFull: Vaduganathan M
      – PersonEntity:
          Name:
            NameFull: Brinker M
      – PersonEntity:
          Name:
            NameFull: Edfors R
      – PersonEntity:
          Name:
            NameFull: Li N
      – PersonEntity:
          Name:
            NameFull: Scheerer MF
      – PersonEntity:
          Name:
            NameFull: Scott C
      – PersonEntity:
          Name:
            NameFull: Nangaku M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 08
              Text: 2025 Aug 07
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1533-4406
          Numbering:
            – Type: volume
              Value: 393
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: The New England journal of medicine
              Type: main
ResultId 1